参天製薬の株価時系列
| 日付 | 始値 | 高値 | 安値 | 終値 | 前日比 | 騰落率 | 出来高 |
|---|---|---|---|---|---|---|---|
| 2023/01/25 | 1,019 | 1,025 | 1,008 | 1,022 | +3 | +0.3% | 1,967,100 |
| 2023/01/24 | 1,037 | 1,038 | 1,019 | 1,019 | -12 | -1.2% | 1,931,400 |
| 2023/01/23 | 1,030 | 1,032 | 1,022 | 1,031 | +5 | +0.5% | 1,216,400 |
| 2023/01/20 | 1,020 | 1,029 | 1,012 | 1,026 | +6 | +0.6% | 1,124,200 |
| 2023/01/19 | 1,024 | 1,030 | 1,018 | 1,020 | -4 | -0.4% | 812,800 |
| 2023/01/18 | 1,007 | 1,031 | 1,007 | 1,024 | +18 | +1.8% | 975,500 |
| 2023/01/17 | 1,000 | 1,009 | 997 | 1,006 | +1 | +0.1% | 1,033,400 |
| 2023/01/16 | 1,010 | 1,017 | 1,004 | 1,005 | -9 | -0.9% | 986,100 |
| 2023/01/13 | 1,026 | 1,038 | 1,010 | 1,014 | -23 | -2.2% | 1,443,200 |
| 2023/01/12 | 1,049 | 1,053 | 1,036 | 1,037 | -4 | -0.4% | 1,012,300 |
| 2023/01/11 | 1,028 | 1,047 | 1,027 | 1,041 | +24 | +2.4% | 1,993,900 |
| 2023/01/10 | 1,027 | 1,038 | 1,014 | 1,017 | -9 | -0.9% | 2,446,300 |
| 2023/01/06 | 1,038 | 1,042 | 1,020 | 1,026 | -4 | -0.4% | 2,009,900 |
| 2023/01/05 | 1,035 | 1,036 | 1,016 | 1,030 | -8 | -0.8% | 2,285,300 |
| 2023/01/04 | 1,064 | 1,064 | 1,037 | 1,038 | -36 | -3.4% | 1,692,200 |
| 2022/12/30 | 1,078 | 1,084 | 1,072 | 1,074 | -4 | -0.4% | 815,500 |
| 2022/12/29 | 1,088 | 1,091 | 1,073 | 1,078 | -8 | -0.7% | 785,700 |
| 2022/12/28 | 1,082 | 1,088 | 1,075 | 1,086 | +4 | +0.4% | 774,400 |
| 2022/12/27 | 1,091 | 1,095 | 1,082 | 1,082 | -8 | -0.7% | 737,100 |
| 2022/12/26 | 1,087 | 1,096 | 1,083 | 1,090 | +1 | +0.1% | 671,300 |
| 2022/12/23 | 1,084 | 1,095 | 1,083 | 1,089 | -4 | -0.4% | 1,070,800 |
| 2022/12/22 | 1,100 | 1,101 | 1,087 | 1,093 | -12 | -1.1% | 1,154,200 |
| 2022/12/21 | 1,098 | 1,114 | 1,093 | 1,105 | +7 | +0.6% | 1,739,400 |
| 2022/12/20 | 1,112 | 1,121 | 1,083 | 1,098 | -13 | -1.2% | 1,426,900 |
| 2022/12/19 | 1,114 | 1,119 | 1,106 | 1,111 | -7 | -0.6% | 1,496,300 |
| 2022/12/16 | 1,117 | 1,131 | 1,111 | 1,118 | -7 | -0.6% | 1,586,700 |
| 2022/12/15 | 1,137 | 1,140 | 1,125 | 1,125 | -15 | -1.3% | 1,034,900 |
| 2022/12/14 | 1,150 | 1,159 | 1,139 | 1,140 | -4 | -0.3% | 910,700 |
| 2022/12/13 | 1,137 | 1,153 | 1,136 | 1,144 | +9 | +0.8% | 1,272,500 |
| 2022/12/12 | 1,126 | 1,142 | 1,123 | 1,135 | -1 | -0.1% | 1,051,700 |
| 2022/12/09 | 1,142 | 1,155 | 1,133 | 1,136 | -14 | -1.2% | 1,923,300 |
| 2022/12/08 | 1,153 | 1,157 | 1,143 | 1,150 | +4 | +0.3% | 2,001,700 |
| 2022/12/07 | 1,138 | 1,156 | 1,134 | 1,146 | -8 | -0.7% | 1,626,400 |
| 2022/12/06 | 1,132 | 1,167 | 1,130 | 1,154 | +25 | +2.2% | 2,486,300 |
| 2022/12/05 | 1,130 | 1,138 | 1,105 | 1,129 | +21 | +1.9% | 2,179,100 |
| 2022/12/02 | 1,100 | 1,116 | 1,091 | 1,108 | +7 | +0.6% | 2,036,500 |
| 2022/12/01 | 1,112 | 1,117 | 1,089 | 1,101 | -13 | -1.2% | 1,643,200 |
| 2022/11/30 | 1,111 | 1,128 | 1,111 | 1,114 | -11 | -1% | 2,474,100 |
| 2022/11/29 | 1,142 | 1,142 | 1,123 | 1,125 | -20 | -1.7% | 3,412,600 |
| 2022/11/28 | 1,160 | 1,169 | 1,142 | 1,145 | -11 | -1% | 1,523,900 |
| 2022/11/25 | 1,158 | 1,170 | 1,150 | 1,156 | +6 | +0.5% | 1,544,300 |
| 2022/11/24 | 1,154 | 1,160 | 1,144 | 1,150 | +8 | +0.7% | 1,674,200 |
| 2022/11/22 | 1,126 | 1,148 | 1,125 | 1,142 | +20 | +1.8% | 2,003,700 |
| 2022/11/21 | 1,118 | 1,127 | 1,111 | 1,122 | +13 | +1.2% | 1,967,900 |
| 2022/11/18 | 1,100 | 1,116 | 1,097 | 1,109 | +7 | +0.6% | 2,425,600 |
| 2022/11/17 | 1,090 | 1,115 | 1,083 | 1,102 | +12 | +1.1% | 2,402,100 |
| 2022/11/16 | 1,070 | 1,091 | 1,066 | 1,090 | +24 | +2.3% | 2,367,700 |
| 2022/11/15 | 1,064 | 1,072 | 1,058 | 1,066 | +4 | +0.4% | 1,949,000 |
| 2022/11/14 | 1,039 | 1,070 | 1,038 | 1,062 | +27 | +2.6% | 2,811,400 |
| 2022/11/11 | 1,029 | 1,043 | 1,029 | 1,035 | +9 | +0.9% | 2,202,400 |
451～
500
件表示中 / 3586件
類似銘柄と比較する
現在ご覧いただいている「参天薬」と類似性の高い銘柄をピックアップ。投資家が注目しているデータで比較できるようになっています。銘柄選びの参考情報としてご活用ください。
| 銘柄名 | 最低購入代金 | 売上高 成長率 |
経常 増益率 |
配当 利回り |
PER | PBR | 直近のチャート | 特色 |
|---|---|---|---|---|---|---|---|---|
| 参天薬 | 167,000円 | 0.0% | +50.6% | 2.04% | 17.79倍 | 2.00倍 |
|
緑内障、加齢黄斑変性、ドライアイ治療薬など眼科用医薬品首位。一般用目薬「サンテ」が有名 |
| 小野薬 | 174,700円 | -3.5% | -50.2% | 4.58% | 14.15倍 | 1.05倍 |
|
医療用医薬品専業の中堅。自社開発品多い。先駆的がん免疫阻害剤「オプジーボ」が成長牽引 |
| ロート | 280,800円 | +18.2% | +4.2% | 1.18% | 19.90倍 | 2.54倍 |
|
一般用医薬品の目薬で世界首位。「肌研」が急成長しスキンケアが柱に。アジアなど海外積極進出 |
| ツムラ | 485,800円 | +22.6% | +68.1% | 2.80% | 12.94倍 | 1.25倍 |
|
医療用漢方薬で国内シェア８割超。高齢者、がん支持療法、女性関連の３領域を重点に市場深耕 |
| 久光薬 | 427,700円 | +7.3% | -3.8% | 2.10% | 19.85倍 | 1.15倍 |
|
貼る鎮痛消炎剤首位。医療用シェア５割。大衆薬「サロンパス」で有名。米国、中国など海外強化 |
市場注目の銘柄
チャート関連のコラム
